SEC Filing Analysis: INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: EVP & President, International, Harvinder Singh, acquired 11,965 shares through the vesting of Restricted Stock Units (RSUs) and subsequently disposed of 3,281 shares in a non-discretionary transaction to cover tax liabilities. The net result is an increase of 8,684 shares to the insider's holdings.
• Market Impact: This event is generally considered neutral. The sale was an automatic "sell-to-cover" action, not a discretionary decision reflecting the insider's sentiment on the company's future prospects. The primary event is the vesting of a long-term incentive award.

Company Information

Field	Value
Company	INTEGRA LIFESCIENCES HOLDINGS CORP
Ticker Symbol	IART
CIK	0000917520
Industry	Surgical & Medical Instruments & Apparatus

Insider Information

Field	Value
Name	Singh Harvinder
CIK	0001949782
Title/Position	EVP & PRESIDENT, INTERNATIONAL
Relationship	Officer

Transaction Details

This filing reports two key non-derivative transactions related to the vesting of RSUs.

Transaction 1: Acquisition via RSU Vesting

Field	Value
Form Type	4
Transaction Date	2025-10-12
Transaction Code	M (Exercise or conversion of derivative security)
Security Type	Common Stock
Shares Involved	11,965
Price Per Share	$0.00
Total Value	$0.00
Shares Owned After	25,217
Ownership Type	Direct

Transaction 2: Disposition for Tax Withholding

Field	Value
Form Type	4
Transaction Date	2025-10-12
Transaction Code	F (Payment of tax liability by withholding security)
Security Type	Common Stock
Shares Involved	3,281
Price Per Share	$13.34
Total Value	$43,770.54
Shares Owned After	21,936
Ownership Type	Direct

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale (Code 'F') is an automated, non-discretionary transaction to satisfy tax obligations arising from the RSU vesting (Code 'M'). It does not reflect a voluntary decision by the insider to reduce their stake. The market typically views such transactions as routine and non-indicative of insider sentiment.

Volume & Sentiment

• Expected Volume Impact: Minimal. Sell-to-cover transactions are often handled by brokers in a way that minimizes market disruption.
• Sentiment Indicator: Neutral. The key event is the vesting of a multi-year compensation award, which aligns the executive with long-term shareholders. The tax sale is a mechanical part of this process.

Investment Insights

Positive Market Indicators

• Increased Holdings: The insider's net position in the company increased by 8,684 shares, strengthening their alignment with shareholder interests.
• Long-Term Incentive: The vesting is part of a long-term incentive plan granted in 2022, indicating the executive has met performance or time-based criteria over a multi-year period.

Risk Factors

• No direct risk factors are indicated by this specific transaction, as it is a standard part of executive compensation.

Key Takeaways

1. An executive received a significant number of shares as part of their long-term compensation.
2. A portion of the vested shares was automatically sold to cover taxes, a common and non-discretionary event.
3. The insider's overall ownership stake in the company has increased, which is generally a positive sign of alignment.

Contextual Analysis

Timing Significance

• The transaction occurred on October 12, 2025, which, according to footnote 2, was the third anniversary of the grant date (October 12, 2022). This confirms the vesting was scheduled and not based on any immediate market event.

Transaction Context

• Footnote 1 explicitly clarifies the nature of the 'F' transaction: "Represents shares withheld to satisfy the reporting person's tax withholding obligation with respect to 11,965 shares of common stock issued upon the vesting of time based restricted stock units... The reporting person retained the remaining 8,684 shares." This removes any ambiguity about the nature of the sale.

Company Context

• This transaction should be viewed in the context of Integra LifeSciences' overall executive compensation strategy, which uses equity to retain and incentivize key leaders.

Risk Assessment

Risk Level: Low

Risk Factors

• The transaction itself presents no material risk, as it is a transparent and routine compensation-related event.

Market Considerations

• Investors should understand the difference between a discretionary open-market sale and a non-discretionary sell-to-cover transaction.
• This filing provides insight into the company's compensation structure and the vesting schedules for its executives.

---

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR